|
Development of Mithramycin Analogs for Ewing sarcoma |
Van Andel Research Institute |
Northwestern Mutual Foundation |
|
Phase I Study of Lentivirus Engineered Autologous AML Cells Expressing IL-12 in Children and Young Adults with Relapsed AML |
Children’s Hospital of Wisconsin - Milwaukee |
Northwestern Mutual Foundation |
|
Identification of Hypoxia-induced Pathways Driving Ewing sarcoma Metastases |
Georgetown University |
Northwestern Mutual Foundation |
|
Optimizing Conformation Disrupting Aurora Kinase Inhibitors to Treat MYCN Amplified Neuroblastoma |
University of California San Francisco |
Northwestern Mutual Foundation |
|
Studies of Invadopodia Formation in Ewing sarcoma |
University of Michigan |
Northwestern Mutual Foundation |
|
Validating a Mouse Model of Alveolar Rhabdomyosarcoma |
Duke University |
Northwestern Mutual Foundation |
|
Molecular Basis of ALK Inhibition Resistance in High-risk Neuroblastoma |
Dana-Farber Cancer Institute |
Northwestern Mutual Foundation |
|
Genetically Engineered T Cells as Therapy for Pediatric Glioma |
Baylor College of Medicine |
Northwestern Mutual Foundation |
|
Single-cell RNA-seq Profiling of Transcriptional Transition States During Human Retinoblastoma |
Children’s Hospital Los Angeles |
Northwestern Mutual Foundation |
|
Role of Kindlin-3 In Natural Killer Cell Mediated Tumor Killing |
Children’s Hospital of Wisconsin - Milwaukee |
Northwestern Mutual Foundation |